Public Health
Volume 121, Issue 9 , Pages 690-695 , September 2007

Implications of the International Health Regulations (2005) for communicable disease surveillance systems: Tunisia's experience

  • S. Lyons

      Affiliations

    • European Programme for Intervention Epidemiology Training, Department of Epidemic and Pandemic Alert & Response, World Health Organization, 1211 Geneva 27, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41227915860; fax: +41227911374.
    • ,
  • A. Zidouh

      Affiliations

    • Eastern Mediterranean Regional Office, The World Health Organization, Cairo, Egypt
    • ,
  • M. Ali Bejaoui

      Affiliations

    • Direction des Soins de Santé de Base, Tunis, Tunisia
    • ,
  • M. Ben Abdallah

      Affiliations

    • Institut de Cancérologie Salah Azaïez, Tunis, Tunisia
    • ,
  • S. Amine

      Affiliations

    • Département de Microbiologie, Faculté de Médecine de Tunis, Tunisia
    • ,
  • M. Garbouj

      Affiliations

    • Direction des Soins de Santé de Base, Tunis, Tunisia
    • ,
  • J. Fitzner

      Affiliations

    • World Health Organization, Geneva, Switzerland

Received 3 June 2006 ,Revised 17 January 2007 ,Accepted 20 February 2007.

References 

  1. World Health Organization. International Health Regulations. Available at: 〈http://www.who.int/csr/ihr/en/〉 [accessed February 2007].
  2. World Health Organization. Frequently asked questions about the International Health Regulations. Available at: 〈http://www.who.int/csr/ihr/howtheywork/faq/en/〉 [accessed February 2007].
  3. Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR 2001; 50 (RR-13).
  4. Buehler J, Hopkins R, Overhage JM, Sosin DM, Tong V. CDC Working Group. Framework for evaluating public health surveillance systems for early detection of outbreaks. MMWR Recomm Rep. 2004;53(RR-5):1–11
  5. World Health Organization. The designation or establishment of National IHR Focal Points. Available at: 〈http://www.who.int/csr/ihr/nfp/en/index.html〉 [accessed February 2007].
  6. World Health Organization. Assessment of the national communicable disease surveillance and response system, Ethiopia. Wkly Epidemiol Rec 2001;76:9–16.
  7. Valenciano M, Bergeri I, Jankovic D, Milic N, Parlic M, Coulombier D. Strengthening early warning function of surveillance in the Republic of Serbia: lessons learnt after a year of implementation. Euro Surveill. 2004;9:24–26
  8. Canton R. Role of the microbiology laboratory in infectious disease surveillance, alert and response. Clin Microbiol Infect. 2005;11(Suppl1):3–8
  9. Thacker SB, Buffington J. Applied epidemiology for the 21st century. Int J Epidemiol. 2001;30:320–325
  10. Khan MI, Sahito SM, Khan MJ, Wassan SM, Shaikh AW, Maheshwari AK, et al. Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial. Bull World Health Organ. 2006;84:72–77

PII: S0033-3506(07)00076-5

doi: 10.1016/j.puhe.2007.02.013

Public Health
Volume 121, Issue 9 , Pages 690-695 , September 2007

Article Tools